METABOLOMICS - An Exclusive Market Insight Report Update
Metabolites are compounds of low molecular weight, which determine the unique characteristics (phenotype) of an organism.

Global metabolomics market is projected to grow at 23.38% compounded annually from 2005 through 2015. Major pharmaceutical companies have been comparatively slow to adopt, as against the wide use of genomics and proteomics. Increasing use of technology is winning over many skeptics. For the past few years, the most commonly used methodologies in systems biology for exploring drug discovery have been genomics and proteomics. Now, metabolomics complements these two methods offering scientists a powerful tool that can uncover enormous amounts of information. The main difference between genomics/proteomics and metabolomics is that while the earlier methods studied genes and proteins, metabolomics focuses on metabolites, which are the substrates and end products of enzymatic reactions. Metabolites are compounds of low molecular weight, which determine the unique characteristics (phenotype) of an organism. This facilitates the identification of specific biological conditions, whether they are healthy or diseased.
While work on detecting and quantifying several metabolites has been continuing for decades, it is only now that scientists are able to compile a complete metabolic profile of an organism. Today research in metabolomics is directed at tracing out specific metabolites corresponding with specific disease states to facilitate drug development. Though metabolomics is still in evolution stage, biotechnology and/or pharmaceutical industry is expected to apply this technology more intensely in the near future.
About RI Technologies
RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.
###
Tag Words:
metabolomics
Categories: Research
Press Release Contact
Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837 for your biotechnology and healthcare market research report requirements. We provide 24/7 online.
Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837 for your biotechnology and healthcare market research report requirements. We provide 24/7 online.